Certificate of Free Sale Requirements: Issuers, Validity and Legalisation

1. Key takeaways

Nicaragua requires a Certificate of Free Sale (Certificado de Libre Venta, CLV) or an equivalent document under item 7 of Chapter 6 of NTON 24001:2023. The CLV must be issued by the competent authority of the country of manufacture or by a PAHO/WHO regional reference authority; where it states no expiry date, it is treated as valid for two years from the date of issue. An original or a notarially certified copy must be filed, in Spanish or with a notarially certified translation, and it must carry an apostille or consular legalisation. NOTA 1 additionally requires the CLV to identify the manufacturer and its address.

• Two issuing routes are accepted: the competent authority of the country of manufacture, or a PAHO/WHO regional reference authority.
• The two-year period is a default, not a statutory validity: a date printed on the certificate prevails over it.
• The CLV must name the manufacturer and its address, and those details must match the application form.
• The legalisation chain has three layers, all of which must be complete before filing.
• Devices manufactured in Nicaragua obtain their CLV from DDM under Chapter 5, Article 12 and Annex E, rather than from a foreign authority.

2. Legal basis

The provisions below collect the CLV requirements in one place, including the sentence on the FDA certificate that sits at the end of the same item, and the domestic route for locally manufactured devices.

3. Expert insights

Insight 1: the issuing body is offered as a dual route, either the competent authority of the country of manufacture or una autoridad de referencia regional según OPS/OMS. This gives companies an alternative where no CLV can be obtained at home, and it is one of the points on which Nicaragua is relatively flexible in its evidentiary requirements.

Insight 2: the two years are a default validity rather than a statutory one. The text reads en caso de que el documento no especifique fecha de vencimiento se tomará validez de 2 años desde su fecha de emisión: where the CLV states its own expiry, that date governs, and only in the absence of a date is the two-year presumption applied. This is a different rule from the six months attached to the ROC, and the two cannot be substituted for one another.

Insight 3: the NOTA 1 requirement that the CLV identify the manufacturer and its address is a substantive point that is often overlooked. A CLV that names only the product, without the manufacturer and its address, will attract a correction request. The manufacturer details entered in blocks f and h of item 2 of Chapter 6 must correspond to those on the certificate.

Insight 4: the legalisation chain is cumulative: an original or notarially certified copy, plus Spanish or a notarially certified translation, plus an apostille or consular legalisation. All three layers must be present, and a missing layer means the document is returned. The requirement is of the same standard as that applied to the CE certificate under item 9.

Insight 5: the FDA certificate sits in the same item as the CLV but carries a different condition. Item 7 requires the CLV in its main body, and adds in its closing sentence that the FDA certificate is mandatory only for products manufactured in the United States. Two sentences in one item with different conditions of application are easily misread together as a requirement for both documents.

Insight 6: products manufactured in Nicaragua do not follow the foreign CLV route but receive a CLV from DDM. Article 12 of Chapter 5 and Annex E set out the domestic manufacturer’s path, with a processing time of ten working days and a requirement that the registration retain at least six months of validity. The CLV is thus both an admission document and, in Nicaragua, a certificate that domestic products may apply for.

4. Practical recommendations

• Apply first to the competent authority of the country of manufacture; where that is not possible, assess the PAHO/WHO regional reference authority route.
• Ask for the CLV to identify the manufacturer and its address under NOTA 1, and reconcile those details with blocks f and h of the application form.
• Where the CLV states an expiry date, follow it; where it does not, count two years from issue and schedule the replacement certificate accordingly at renewal.
• Complete all three legalisation layers in one pass: notarial certification, notarially certified translation, and apostille or consular legalisation.
• Confirm separately the mandatory status of the FDA certificate for US-manufactured products, and do not prepare FDA or CE certificates for products from other origins unless required.
• For products manufactured in Nicaragua, apply to DDM for the CLV under Chapter 5, Article 12 and Annex E.

5. Verification checklist

• □ The CLV has been issued by the competent authority of the country of manufacture or by a PAHO/WHO regional reference authority
• □ The CLV identifies the manufacturer and its address and matches blocks f and h of the application form (NOTA 1)
• □ The validity of the CLV is confirmed: a stated date governs, otherwise two years from issue
• □ All three legalisation layers are complete: notarial certification, notarially certified translation, apostille or consular legalisation
• □ The mandatory status of the FDA and CE certificates has been confirmed against the country of origin
• □ For devices manufactured in Nicaragua, the CLV has been requested from DDM under Chapter 5, Article 12 and Annex E

Related reading: [The FDA certificate covers US goods only, the CE certificate EU goods only](/nicaragua-medical-device-registration/fda-and-ce-certificate-scope/) | [ISO 13485 and MDSAP: the waiver of six monograph items](/nicaragua-medical-device-registration/iso-13485-and-mdsap-exemption/) | [CLV for domestically manufactured devices: the ten working days of Annex E](/nicaragua-medical-device-registration/clv-for-nationally-manufactured-devices/)

Regulatory information verified as of 29 October 2026.

How GRZAN can help. GRZAN provides medical device and IVD registration, quality system, authorised representative and local testing support for the Nicaraguan market. Our team manages Ministry of Health (MINSA) sanitary registration applications, prepares Spanish-language dossiers, and supports post-market vigilance obligations. Business enquiries: info@grzanglobal.com